Profusa, Inc. files 8-K covering a debt obligation
The Nasdaq-listed medical instruments company submitted a current report dated September 1, 2026 that includes debt-related disclosure items.
Profusa, Inc., a Delaware-incorporated maker of surgical and medical instruments and apparatus listed on Nasdaq under the ticker PFSA, filed an 8-K current report on September 1, 2026.[1][2]
The filing carries accession number 0001213900-26-095984 and includes Items 1.01, 2.03, and 9.01, which cover entry into a material agreement and direct financial obligations.[1]
The same company had previously filed an 8-K on August 21, 2026 that was also tied to a debt obligation.[3]
That earlier filing carried accession number 0001213900-26-092597.[3]